Three Indian Firms Line Up To Make TB Drug Bedaquiline As Patent Expires
Mumbai : As the primary patent on Tuberculosis drug Bedaquiline expires in India and other countries on Tuesday, at least three Indian companies — Lupin, Natco and Macleods — are poised…
Regulator should look at factors behind failing of a drug during sample test and share more details: Expert
The drug regulator should look at the various factors that go behind failing of a drug during pharma company sample test before finalising the list of Not of Standard Quality…
Fake diabetes, multivitamin medicines worth Rs 55 lakh for sale in Delhi, Haryana seized in Himachal Pradesh’s Baddi
Solan : Exposing yet another alleged laxity of the officers of the drug control department, a spurious drugs consignment having costing Rs 55 lakh was seized by a team of drug officials…
DCGI Warns Of Stringent Action For Quality Lapses As International Community Started Doubting Indian Drugs
Chennai : Hailing the stellar performance of the Indian pharmaceutical industry on one side but raising quality concerns on the other in the wake of quality alerts issued by WHO on…

Diabetic drug metformin found to act on brain
Hetero debuts semaglutide generic in emerging markets
LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial
Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority
Stem cell therapy for autism illegal: NMC advisory
India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework
Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic
NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise
Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha
Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS